2022 Spring Tele-Conference

Monday, May 2, 2022 – 10:00 am – 3:00 pm (MDT) via Zoom

The CNS Board is delighted to announce our teleconference program for the annual Spring Conference. Our program this year features national speakers Drs. Ryan Schroeder and Kevin Duff, whose sessions will be both informative and thought-provoking. These are intermediate-level presentations appropriate for neuropsychologists, neuropsychology trainees, and similar professionals. Special pricing for CNS members is available!

Session 1 – Ryan Schroeder, PsyD, ABPP-CN
Identifying, explaining, and managing noncredible neuropsychological presentations in clinical practice

Neuropsychologists previously believed that invalidity was largely confined to forensic settings. Recent research, however, has clearly documented that invalidity also happens – sometimes commonly – in clinical settings. This presentation will review the frequency of invalidity in various clinical settings along with factors that are commonly linked to hidden external incentives. The role of clinical judgment in validity assessment, incorporation of time efficient validity testing, utilization of abbreviated versions of validity tests, and the use of validity testing with culturally diverse patients will be discussed. Common explanations that have been posed for patients invalidating testing in clinical settings will be reviewed with a discussion of the empirical evidence for and against these commonly provided explanations. A relatively new model for managing invalidity and providing feedback to patients who invalidate testing will be described.

Session 2 – Kevin Duff, PhD, ABPP-CN
The incredibly complex world of reliable change made surprisingly simple

Serial neuropsychological assessments are complicated to interpret due to practice effects, regression to the mean, and “normal” change in clinical conditions. This webinar will introduce attendees to the basic concepts associated with change (e.g., reliability, practice effects, retest interval, etc.), common methods of assessing change (e.g., reliable change index, regression-based change formula), and how these formulae are calculated. Case examples will be used to guide the presentation. It will then expand these basic building blocks to address more complex issues in assessing change (e.g., applying change formulae to individual tests vs. an entire battery, examining change across more than two assessments). Finally, some of the presenter’s research on the ability of short-term practice effects to inform diagnosis, prognosis, treatment response, and brain pathology in Mild Cognitive Impairment and Alzheimer’s disease will be discussed.


Session 1: Noncredible Presentations 10:00 AM – 12:00 PM (MDT)*
Session 2: Reliable Change 1:00 PM – 3:00 PM (MDT)*

Static course offerings for Session 1 and 2 will be offered for 1 week after the live event (until 5/9/2022). Attendees of the live courses must attend the full session + complete a questionnaire and post-test to receive CE credit. Static course attendees must view the entire recording + complete a questionnaire and more comprehensive post-test to document full attendance. Questionnaires and quizzes will be due on 5/9/2022 to get CE certificates.*


Zoom – both Live and Static versions of the talks will be provided. Please ensure you indicate which version you will be attending during registration.


CNS Member Rates (to get CE Credits) – $25 for 1 session, $40 for both

Non-Member Professionals (to get CE credits) – $30 for 1 session, $50 for both

CNS Member Student (no CE credits) FREE

Non-CNS Member Student (no CE credits) $15 for 1 session, $20 for both

Discount codes will be sent to active CNS members via the listserv to obtain the member discount.
Registration Deadline: April 25, 2022

Register Now

Conference Objectives

For Session 1 (Dr. Schroeder), participants attending the conference will be able to:

  1. Summarize the frequency of and common reasons for invalidity in clinical settings.
  2. Select and apply patient appropriate and time efficient validity test in clinical settings.
  3. Recognize appropriate and inaccurate explanations of invalidity in clinical settings.
  4. Apply knowledge learned to manage and provide feedback to patients who invalidate testing.

For Session 2 (Dr. Duff), participants attending the conference will be able to:

  1. Describe the role that test variables, testing situation variables, and individual variables have on assessing cognitive change.
  2. List common methods for assessing change in patients.
  3. Compute and apply basic mathematical formula for assessing cognitive change across a number of scenarios.
  4. Recognize the value of short-term practice effects in evaluating a patient’s diagnosis, prognosis, potential for treatment response, and brain pathology.

*This program includes up to 4.0 CE. The University of Denver, Graduate School of Professional Psychology (GSPP) is approved by the American Psychological Association to sponsor continuing education for psychologists. GSPP maintains responsibility for this program and its content.

Disclosure of Commercial Support/Relationships
Dr. Schroeder receives royalties from Guilford Press for his work as an editor on the book Validity Assessment in Clinical Neuropsychological Practice: Evaluating and Managing Noncredible Performance.

Dr. Duff has received grant support from the NIH and GE for some of the research to be discussed.

CNS will comply with all legal and ethical responsibilities to be non-discriminatory in promotional activities, program content and in the treatment of program participants. The monitoring and assessment of compliance with these standards will be the responsibility of the President serving as the education Chair for the conference in consultation with the members of the CNS Board.

For additional information, questions, or grievance procedures, contact the CNS board.

Scroll To Top